Sensus Healthcare (SRTS) Change in Accured Expenses (2017 - 2026)
Sensus Healthcare's (SRTS) quarterly Change in Accured Expenses came in at $1.3 million in Q1 2026, up 63.71% year-on-year from $824000.0 in Q1 2025, and up 159.27% quarter-over-quarter from -$2.3 million in Q4 2025.
Sensus Healthcare (SRTS) Change in Accured Expenses (2017 - 2026) Analysis & Trends
Sensus Healthcare's Change in Accured Expenses history runs 10 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 63.71% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was -$943000.0, a 148.81% decrease from a year earlier, with the FY2025 full-year figure at -$1.5 million, down 172.75% from the prior year.
- Change in Accured Expenses advanced to $1.3 million in Q1 2026 per SRTS's latest filing, from -$2.3 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $1.3 million in Q1 2026 and bottomed at -$2.3 million in Q4 2025.
- The 5-year median for Change in Accured Expenses is $63000.0 (2022), against an average of -$1764.7.
- Across the five-year window, Change in Accured Expenses tumbled 1330.43% in 2023 and jumped 1087.93% in 2024, its largest moves.
- Year by year, Change in Accured Expenses stood at $638000.0 in 2022, then slumped by 289.03% to -$1.2 million in 2023, then surged by 169.49% to $838000.0 in 2024, then tumbled by 371.6% to -$2.3 million in 2025, then surged by 159.27% to $1.3 million in 2026.
- Per Business Quant, the three latest SRTS Change in Accured Expenses figures stand at $1.3 million (Q1 2026), -$2.3 million (Q4 2025), and $254000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sensus Healthcare | 50.14 Mn | 31.81 Mn | - | 1.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.35 Mn |
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | -2.28 Mn |
| Dec 31, 2025 | -2.28 Mn |
| Sep 30, 2025 | 254,000.00 |
| Sep 30, 2025 | 254,000.00 |
| Jun 30, 2025 | -270,000.00 |
| Jun 30, 2025 | -270,000.00 |
| Mar 31, 2025 | 824,000.00 |
| Mar 31, 2025 | 824,000.00 |
| Dec 31, 2024 | 838,000.00 |
| Dec 31, 2024 | 838,000.00 |
| Sep 30, 2024 | 689,000.00 |
| Sep 30, 2024 | 689,000.00 |
| Jun 30, 2024 | -419,000.00 |
| Jun 30, 2024 | -419,000.00 |
| Mar 31, 2024 | 910,000.00 |
| Mar 31, 2024 | 910,000.00 |
| Dec 31, 2023 | -1.21 Mn |
| Dec 31, 2023 | -1.21 Mn |